BioStock: Iconovo establishes Nordic pharmaceutical sales
Iconovo has started building up the subsidiary Iconovo Pharma, which will sell and market pharmaceuticals in the Nordic region. Inhalation products are a natural focus area for Iconovo Pharma, but they may also consider including other products if both the product and business model are attractive. The portfolio will consist of in-licensed, complex generic products and proprietary inhalation products. The first proprietary product in the portfolio is expected to be a generic equivalent of AstraZeneca’s blockbuster Symbicort Turbuhaler. BioStock contacted Fredrik Radencrantz, Director Business